AI assistant
Sending…
PERRIGO Co plc — Director's Dealing 2014
Nov 5, 2014
31387_dirs_2014-11-05_c9550682-5af0-4498-b75b-0663ab6133bd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PERRIGO Co plc (PRGO)
CIK: 0001585364
Period of Report: 2014-11-03
Reporting Person: Brown Judy L (Executive VP & CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-11-03 | Ordinary Shares | M | 1515 | $35.85 | Acquired | 8960 | Direct |
| 2014-11-03 | Ordinary Shares | S | 1315 | $160.65 | Disposed | 7645 | Direct |
| 2014-11-03 | Ordinary Shares | S | 200 | $160.66 | Disposed | 7445 | Direct |
| 2014-11-03 | Ordinary Shares | M | 2000 | $58.82 | Acquired | 9445 | Direct |
| 2014-11-03 | Ordinary Shares | S | 2000 | $160.56 | Disposed | 7445 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-11-03 | Employee Stock Option Right to Buy | $35.85 | M | 1515 | Disposed | 2018-08-25 | Ordinary Shares (1515.0) | Direct |
| 2014-11-03 | Employee Stock Option Right to Buy | $58.82 | M | 2000 | Disposed | 2020-08-19 | Ordinary Shares (2000.0) | Direct |
Footnotes
F1: This transaction was effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on 6/13/2014. This 10b5-1 sales plan will expire on the close of business 12/01/2014.
F2: Exercisable in 3 equal annual installments beginning 8/25/2009
F3: Exercisable in 3 equal annual installments beginning 8/19/2011.
More from PERRIGO Co plc
Earnings Release
2026
May 6
Regulatory Filings
2026
May 5
Transaction in Own Shares
2026
May 5
Share Issue/Capital Change
2026
May 5
Share Issue/Capital Change
2026
May 5
Regulatory Filings
2026
May 5
Regulatory Filings
2026
Apr 22
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 20
Proxy Solicitation & Information Statement
2026
Mar 20